Compared with other countries, the US is again seeing exorbitant prices for a medicine—even one it helped develop.

In the current COVID-19 booster campaign, the Centers for Disease Control and Prevention is paying around $82 for each dose of Moderna’s 2023–2024 updated mRNA COVID-19 vaccine for its program to provide vaccine for the uninsured. That price is a little over three times the $26 per dose the federal government paid for the last updated booster, which was exclusively distributed by the government.

The price hike marks the vaccine’s move from federal distribution to the commercial market. Moderna and rival manufacturer Pfizer raised the US list price of their COVID-19 vaccines by roughly 400 percent. (Moderna’s is listed at $128 and Pfizer’s is $115).

The price hike is particularly remarkable from Moderna, which developed its COVID-19 vaccine with substantial assistance from the federal government. It developed the vaccine in partnership with the National Institutes of Health and got $1.7 billion in federal grant money for its clinical development.

In a March Congressional hearing on the vaccine’s pricing, Moderna’s CEO Stéphane Bancel—who became a billionaire during the pandemic—unabashedly defended quadrupling the price. Specifically, Bancel downplayed the US government’s contribution and suggested the earlier pricing was actually a discount.

“We were under no obligation to do so, but, recognizing the US government’s investments, our company decided to provide the government with a discount,” Bancel said of the $26 per dose pricing.

Sen. Bernie Sanders (I-Vt.), who chaired the hearing, fired back, saying: “This vaccine would not exist without NIH’s partnership and expertise, and the substantial investment of the taxpayers of this country. And here is the ‘thank you’ that the taxpayers of this country received from Moderna for that huge investment: They are thanking the taxpayers of the United States by proposing to quadruple the price of the COVID vaccine.”

Now, adding insult to injury, the European Union may end up paying three times less than the US for the same vaccine. According to a report by the Financial Times, EU health authorities are in the process of negotiating a vaccine supply deal with Moderna—and, so far, the discussed price per dose is just 25 euros, or about $26, which Bancel had suggested previously was a discounted price for the US government. Though the EU’s price is not final, the discussed price in the negotiation is substantially lower than what the US is already forking over for the update shots.

The news, while perhaps enraging, is not surprising. During March’s Congressional hearing, Bancel hinted that the US would not get a good deal on the shots. Sanders asked him the question directly.

“The United States—the people in our country—pay the highest prices in the world for prescription drugs in general… will you at least tell us today that the price you are charging for the vaccine will be lower than what other countries around the world are paying?” Sanders implored.

Bancel eventually replied: “I cannot say the price will be lower than other countries.”

  • Flying Squid
    link
    fedilink
    669 months ago

    If only the U.S. had, say, a single-payer system with the legal ability to negotiate drug prices…

    Nah. It’d never work for some reason or other.

    • ZeroCoolOP
      link
      fedilink
      English
      249 months ago

      Right?

      “ThE Us HaS tHe BeSt HeAlThCaRe iN tHe WoRlD”

      Well, if nobody can access it without immediately taking on a crippling amount of debt then it doesn’t matter how good the quality of that healthcare is. The system is fundamentally broken.

      • @[email protected]
        link
        fedilink
        English
        99 months ago

        Amazingly it is rarely in the top ten for quality, while consistently being the most expensive, often by twice the next most expensive country.

        • @[email protected]
          link
          fedilink
          19 months ago

          You’re calculating things wrong. The US is typically number one in healthcare if you only look at the top 1%, and clearly they are all that matter.

      • @thepianistfroggollum
        link
        English
        69 months ago

        But if we had socialized medicine, I might have to wait a few weeks to get that elective procedure done. That’s unacceptable.

        /s obviously

    • @[email protected]
      link
      fedilink
      English
      89 months ago

      As for the quadrupling of the US’s discount price, Bancel argued that the simple bulk orders for the government were wholly different in nature than the messiness of the commercial market—and that messiness costs extra. During the pandemic, Moderna dealt with one customer (the government) that committed to paying for a set number of doses regardless of whether they made it into arms. And the company delivered those doses to a limited number of federal warehouses. Now, it will have thousands of customers, requiring the company to deal with complex distribution logistics, and to take on the financial risk of manufacturing more doses than are purchased. Moderna will also switch from selling multi-dose vials to single-dose vials, which it sees as more suited for the commercial market. “This is not the same product,” Bancel argued, and the quadrupled price reflects that, he suggested.

      In the article linked in that opening paragraph about his testimony, HE MADE THE CASE FOR SINGLE PAYER. Clearly and unequivocally.

        • @[email protected]
          link
          fedilink
          English
          6
          edit-2
          9 months ago

          Why…would you take this as a comment against YOU?I was piggybacking off what you said to continue pointing to the absurdity? This newly minted billionaire pharma CEO stepped all over his own Bullshit to make the case. He wasn’t purposefully making the case, he was trying to justify the nonsense of what they’re doing and accidentally said “if we had single payer, it’d be cheaper.” While defending their absurd profits. Wasn’t a slight against you, friend.